Deutsche Bank’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.4B | Buy |
12,640,672
+510,948
| +4% | +$96.1M | 0.7% | 21 |
|
|
2026
Q1 | $2.39B | Buy |
12,129,724
+11,864,378
| +4,471% | +$2.29B | 0.79% | 15 |
|
|
2025
Q4 | $48.8M | Buy |
265,346
+90,683
| +52% | +$15.9M | 0.02% | 641 |
|
|
2025
Q3 | $26.8M | Sell |
174,663
-46,026
| -21% | -$6.97M | 0.01% | 770 |
|
|
2025
Q2 | $30.8M | Sell |
220,689
-396,735
| -64% | -$55.6M | 0.01% | 714 |
|
|
2025
Q1 | $90.8M | Buy |
617,424
+535,112
| +650% | +$77.4M | 0.04% | 461 |
|
|
2024
Q4 | $10.8M | Buy |
82,312
+3,019
| +4% | +$423K | ﹤0.01% | 1002 |
|
|
2024
Q3 | $12.4M | Buy |
79,293
+1,450
| +2% | +$234K | 0.01% | 962 |
|
|
2024
Q2 | $12.1M | Sell |
77,843
-175,486
| -69% | -$26.4M | 0.01% | 945 |
|
|
2024
Q1 | $34.3M | Buy |
253,329
+1,818
| +0.7% | +$241K | 0.02% | 657 |
|
|
2023
Q4 | $33.9M | Buy |
251,511
+3,018
| +1% | +$392K | 0.02% | 632 |
|
|
2023
Q3 | $33.7M | Buy |
248,493
+1,213
| +0.5% | +$166K | 0.02% | 568 |
|
|
2023
Q2 | $35.4M | Sell |
247,280
-10,842
| -4% | -$1.6M | 0.02% | 603 |
|
|
2023
Q1 | $35.8M | Buy |
258,122
+3,712
| +1% | +$499K | 0.02% | 604 |
|
|
2022
Q4 | $34.5M | Sell |
254,410
-121,432
| -32% | -$15.2M | 0.02% | 611 |
|
|
2022
Q3 | $41.2M | Sell |
375,842
-58,287
| -13% | -$7.39M | 0.02% | 550 |
|
|
2022
Q2 | $57.4M | Sell |
434,129
-255,777
| -37% | -$33.6M | 0.03% | 481 |
|
|
2022
Q1 | $91.5M | Sell |
689,906
-355,266
| -34% | -$42.6M | 0.04% | 397 |
|
|
2021
Q4 | $122M | Buy |
1,045,172
+286,461
| +38% | +$33.7M | 0.05% | 329 |
|
|
2021
Q3 | $91.1M | Buy |
758,711
+335,647
| +79% | +$39.1M | 0.04% | 406 |
|
|
2021
Q2 | $50.7M | Buy |
423,064
+156,189
| +59% | +$17.1M | 0.02% | 596 |
|
|
2021
Q1 | $26.5M | Buy |
266,875
+1,110
| +0.4% | +$112K | 0.01% | 801 |
|
|
2020
Q4 | $26.6M | Sell |
265,765
-3,833
| -1% | -$406K | 0.02% | 701 |
|
|
2020
Q3 | $29.5M | Sell |
269,598
-45,231
| -14% | -$5.03M | 0.02% | 591 |
|
|
2020
Q2 | $33.3M | Buy |
314,829
+426
| +0.1% | +$44K | 0.03% | 546 |
|
|
2020
Q1 | $28.1M | Sell |
314,403
-56,559
| -15% | -$5.32M | 0.03% | 552 |
|
|
2019
Q4 | $37M | Buy |
370,962
+36,677
| +11% | +$3.45M | 0.02% | 581 |
|
|
2019
Q3 | $29.8M | Buy |
334,285
+85,179
| +34% | +$7.39M | 0.02% | 631 |
|
|
2019
Q2 | $20.6M | Sell |
249,106
-564,377
| -69% | -$44.3M | 0.01% | 936 |
|
|
2019
Q1 | $65.8M | Buy |
813,483
+516,693
| +174% | +$40.7M | 0.04% | 487 |
|
|
2018
Q4 | $22.5M | Sell |
296,790
-35,677
| -11% | -$2.79M | 0.02% | 833 |
|
|
2018
Q3 | $26.3M | Sell |
332,467
-11,620
| -3% | -$879K | 0.01% | 977 |
|
|
2018
Q2 | $24.2M | Buy |
344,087
+101,353
| +42% | +$7.29M | 0.01% | 1065 |
|
|
2018
Q1 | $17M | Buy |
242,734
+33,039
| +16% | +$2.29M | 0.01% | 1221 |
|
|
2017
Q4 | $14.6M | Buy |
209,695
+13,638
| +7% | +$920K | 0.01% | 1217 |
|
|
2017
Q3 | $13.3M | Buy |
196,057
+24,130
| +14% | +$1.52M | 0.01% | 1264 |
|
|
2017
Q2 | $11.7M | Buy |
171,927
+5,874
| +4% | +$384K | 0.01% | 1291 |
|
|
2017
Q1 | $10.3M | Sell |
166,053
-138,480
| -45% | -$8.06M | 0.01% | 1243 |
|
|
2016
Q4 | $16.6M | Buy |
304,533
+33,891
| +13% | +$1.92M | 0.01% | 965 |
|
|
2016
Q3 | $17.8M | Sell |
270,642
-173,937
| -39% | -$11.4M | 0.01% | 979 |
|
|
2016
Q2 | $26.8M | Buy |
444,579
+127,772
| +40% | +$7.42M | 0.02% | 776 |
|
|
2016
Q1 | $17.8M | Sell |
316,807
-10,115
| -3% | -$608K | 0.01% | 960 |
|
|
2015
Q4 | $22.2M | Sell |
326,922
-79,736
| -20% | -$5.23M | 0.02% | 874 |
|
|
2015
Q3 | $25.9M | Sell |
406,658
-280,945
| -41% | -$18.5M | 0.02% | 768 |
|
|
2015
Q2 | $43.8M | Buy |
687,603
+285,701
| +71% | +$19.6M | 0.03% | 585 |
|
|
2015
Q1 | $27.5M | Sell |
401,902
-154,108
| -28% | -$10.7M | 0.02% | 780 |
|
|
2014
Q4 | $39.1M | Sell |
556,010
-442,946
| -44% | -$31.7M | 0.02% | 676 |
|
|
2014
Q3 | $71.4M | Buy |
998,956
+674,774
| +208% | +$49.4M | 0.04% | 432 |
|
|
2014
Q2 | $24.1M | Sell |
324,182
-15,693
| -5% | -$1.13M | 0.02% | 832 |
|
|
2014
Q1 | $22.1M | Buy |
339,875
+67,847
| +25% | +$4.38M | 0.02% | 872 |
|
|
2013
Q4 | $16.1M | Buy |
272,028
+248,195
| +1,041% | +$13.5M | 0.01% | 1044 |
|
|
2013
Q3 | $1.24M | Sell |
23,833
-268,236
| -92% | -$13.5M | ﹤0.01% | 2807 |
|
|
2013
Q2 | $13.8M | Buy |
+292,069
| New | +$14.9M | 0.01% | 1059 |
|
Other funds holding AZN
EP
IA
Deutsche Bank's AZN Position: Q2 2026 in Review
Deutsche Bank increased its AstraZeneca (AZN) stake by 4.2% in Q2 2026, buying an estimated $96.1M and bringing the position to 12,640,672 shares worth $2.4B. The position accounts for 0.7% of the portfolio, ranked #21.
Deutsche Bank first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Deutsche Bank held 12,640,672 shares of AstraZeneca worth $2.4B as of Q2 2026.
- Deutsche Bank bought 510,948 AstraZeneca shares in Q2 2026, an estimated $96.1M.
- AstraZeneca made up 0.7% of Deutsche Bank's portfolio in Q2 2026, its #21 holding.
- Deutsche Bank first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.